Pharm
Paclitaxel
search
Paclitaxel
, Taxol
See Also
Protein-Bound Paclitaxel
Docetaxel
Cabazitaxel
Mitotic Inhibitor Chemotherapy
Chemotherapy
Indications
FDA Approved
Breast Cancer
Kaposi Sarcoma
(AIDs related)
Non-Small Cell Lung Cancer
Ovarian Cancer
Off-Label
Head and neck cancer (advanced)
Gastrointestinal Tract
Adenocarcinoma (gastric, esophageal, colon)
Non-Hodgkin Lymphoma
Pancreatic Cancer
Polycystic Kidney Disease
Prostate Cancer
(
Hormone
refractory)
Transitional Cell Carcinoma (urothelial cancer)
Uterine Cancer
Contraindications
Polyoxyethylated
Castor Oil
(Cremophor EL) allergy
Mechanism
See
Mitotic Inhibitor Chemotherapy
Paclitaxel is a taxane
Antineoplastic Agent
Derived from extract of the Pacific yew tree (Taxus brevifolia)
Paclitaxel has antineoplastic activity as a an antitubulin agent
Binds and stabilizes tubulin
Inhibits microtubule disassembly
Results in
Cell Cycle
arrest in G2/M phase
Paclitaxel induces apoptosis
Binds and blocks apoptosis inhibitor
Protein
Bcl-2 (B-cell
Leukemia
2)
Medications
Paclitaxel injection solution
Doses available from 30 mg/5 ml to 300 mg/50 ml
Dosing
See other references for disease specific dosing protocols
Adverse Effects
Hypersensitivity Reaction
(including
Anaphylaxis
)
Myelosuppression (
Bone Marrow
suppression) with
Neutropenia
Peripheral Neuropathy
Future impaired fertility
Alopecia
Nausea
Myalgias
Cardiac conduction abnormalities
Safety
Avoid in
Lactation
Avoid in pregnancy (all trimesters)
Use reliable
Contraception
Monitoring
Complete Blood Count
Drug Interactions
Agents that increase Paclitaxel levels
Diazepam
Estradiol
Felodipine
Ketoconazole
Resources
Paclitaxel (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea28753a-8631-460a-bfdc-b101eb8ac84a
Paclitaxel (StatPearls)
https://www.ncbi.nlm.nih.gov/books/NBK536917/
Type your search phrase here